Recently, Shirey et al (7) found that Eritoran (E5564), an extremely potent TLR4 antagonist, exhibits a highly protective effect when administered therapeutically to mice with influenza-induced ALI (7). This evidence concerns the gene TLR4 and acute respiratory distress syndrome.